Thorax

Journal

Publication Venue For

  • Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and receptors in type 1, type 2 and type 17 inflammation in cross-sectional asthma study.  75:808-811. 2020
  • Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits.  75:520-527. 2020
  • Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.  73:414-421. 2018
  • Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.  72:318-326. 2017
  • Latent tuberculosis infection screening and treatment in HIV: Insights from evaluation of UK practice.  72:180-182. 2017
  • Biomechanical CT metrics are associated with patient outcomes in COPD.  72:409-414. 2017
  • Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.  71:1082-1090. 2016
  • β-Blockers are associated with a reduction in COPD exacerbations.  71:8-14. 2016
  • Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilator-acquired pneumonia.  70:41-47. 2015
  • Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: Authors' response.  69:1147-1148. 2014
  • Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.  69:409-414. 2014
  • Progress in cystic fibrosis and the CF Therapeutics Development Network.  67:882-890. 2012
  • Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.  67:399-406. 2012
  • Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.  67:12-18. 2012
  • Genome-wide association study of smoking behaviours in patients with COPD.  66:894-902. 2011
  • Intrapulmonary shunting associated with sildenafil treatment in a patient with idiopathic pulmonary arterial hypertension.  66:1097-1098. 2011
  • PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice.  66:788-796. 2011
  • Pneumocystis jirovecii in pleural infection: A nucleic acid amplification study.  66:450-451. 2011
  • Gastro-oesophageal reflux and aspiration in patients with advanced lung disease.  64:167-173. 2009
  • Authors' response.  63:1026. 2008
  • Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.  63:301-305. 2008
  • Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.  63:154-159. 2008
  • Authors' response.  63:1027. 2008
  • Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis.  63:935-936. 2008
  • Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.  62:964-968. 2007
  • Author's reply [6].  62:924. 2007
  • Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection.  61:791-794. 2006
  • Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy.  61:716-721. 2006
  • A&E department: A missed opportunity for diagnosis of TB? [4].  61:364-365. 2006
  • Genotypic variation in Pneumocystis jirovecii isolates in Britain.  60:679-682. 2005
  • Pneumocystis jirovecii infection.  59:731-733. 2004
  • Pneumocystis pneumonia in humans is caused by P jiroveci not P carinii (5) [multiple letters].  59:83-84. 2004
  • Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: A prospective study.  58:594-597. 2003
  • Changes in nitric oxide synthase activity in the porcine lung after birth.  53. 1998
  • Nebulisers for patients with HIV infection and AIDS.  52. 1997
  • Alveolar lymphocytes and macrophages are an important source of HIV-1 in patients with AIDS.  51. 1996
  • Genotypic variants of HIV-1 from peripheral blood and lung of AIDS patients.  51. 1996
  • Authors' Reply.  50:1227. 1995
  • Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200)).  50:1228. 1995
  • Erratum: Inadvertent duplicate publication (Thorax (1995) 50 (191-200)).  50:1228. 1995
  • Interstitial pneumonitis in patients infected with the human immunodeficiency virus.  50:1141-1146. 1995
  • New developments in the pulmonary diseases affecting HIV infected individuals.  50:294-302. 1995
  • Pneumocystis carinii pneumonia.  50:191-200. 1995
  • Role of the human immunodeficiency virus within the lung.  50:567-576. 1995
  • Community acquired lobar pneumonia in patients with HIV infection and AIDS.  49:367-368. 1994
  • Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1.  48:204-207. 1993
  • Histologically atypical Pneumocystis carinii pneumonia.  48:996-1001. 1993
  • Bronchopulmonary Kaposi's sarcoma in patients with AIDS.  47:721-725. 1992
  • Pneumocystis carinii pneumonia.  47:305-314. 1992
  • Arterial desaturation in HIV positive patients undergoing sputum induction.  46:449-451. 1991
  • AIDS and the lung: 5 - Tests giving an aetiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus.  45:62-65. 1990
  • Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage (I: Reply).  45:302. 1990
  • Granulomatous Pneumocystis carinii pneumonia in a patient with the acquired immunodeficiency syndrome.  45:769-771. 1990
  • Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.  45:140-146. 1990
  • Diagnosis of pulmonary disease in human immunodeficiency virus infection: Role of transbronchial biopsy and bronchoalveolar lavage.  44:554-558. 1989
  • Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.  44:559-564. 1989
  • Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.  44:565-569. 1989
  • Infectious complications after heart transplantation.  38:822-828. 1983
  • Technique, complications, and climncal value of endomyocardial biopsy in patients with heterotopic heart transplants.  37:727-731. 1982
  • Empyema after internal jugular catheterisation in rheumatoid arthritis.  36:958-959. 1981
  • Management of oesophageal perforation associated with benign stricture and hiatus hernia by oesophagoplasty and fundoplication.  36:541-542. 1981
  • Pharmacological and hypothermic inhibition of metabolism during myocardial ischaemia.  35:75. 1980
  • Collagen diseases as a cause of constrictive pericarditis.  33:368-371. 1978
  • Incidence of postoperative infection and role of antibiotic prophylaxis in pulmonary surgery.  33:130. 1978
  • Conservative surgery for bronchial adenomata.  31:44-48. 1976
  • Transplantation of the heart and both lungs. I. Historical review..  24:383-390. 1969
  • Transplantation of the heart and both lungs. II. Experimental cardiopulmonary transplantation..  24:391-398. 1969
  • International Standard Serial Number (issn)

  • 0040-6376
  • Electronic International Standard Serial Number (eissn)

  • 1468-3296